Johnson & Johnson Announces Submission of Emergency Use Auth

/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) announced it has submitted data to the U.S. Food and Drug Administration (FDA) to support use of a...

Related Keywords

United States , Johnson , Guillain Barr , Mathai Mammen , None Of The Janssen Pharmaceutical Companies , Company Advac , Janssen Biotech Inc , World Health Organization , Drug Administration , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , Janssen Research Development , National Immunization Technical Advisory Groups Nitags , Exchange Commission , Companies Of Johnson , European Commission On , Strategic Advisory Group Of Experts , Global Head , Janssen Research , New England Journal , Medicinein July , National Immunization Technical Advisory Groups , Conditional Marketing Authorization , European Commission , Emergency Use Listing , Strategic Advisory Group , Emergency Use Authorization , Low Levels , Adverse Event Reporting System , Janssen Biotech , Fact Sheet , Healthcare Providers Administering Vaccine , Vaccination Providers , Pharmaceutical Companies , Infectious Diseases , Private Securities Litigation Reform Act , Annual Report , Note Regarding Forward Looking , Quarterly Report , Johnson Amp ,